---
figid: PMC6723600__biomolecules-09-00345-g001
figlink: /pmc/articles/PMC6723600/figure/biomolecules-09-00345-f001/
number: F1
caption: IL-38 signaling pathways. The N-terminus of IL-38 requires cleavage, but
  which protease(s) is responsible remains unknown. The process may involve an intra-
  or extracellular protease(s). IL-38 is mainly reported to exist in two forms—a truncated
  form and a full-length form. However, which form(s) of IL-38 is naturally present
  in the human body remains unknown. Interleukin-1 receptor 1 (IL-1R1) and IL-36R
  are activated by the agonists IL-1 and IL-36, respectively. The heterodimeric receptor
  complex consisting of IL-1R1 or IL-36R and interleukin-1 receptor accessory protein
  (IL-1RAcP) results in myeloid differentiation primary response 88 (MyD88) recruitment
  through the intracellular toll-interleukin 1 receptor (TIR) domain, and the downstream
  signaling pathways that are activated include (A) the nuclear factor kappa B (NF-κB)
  pathway and (B) the mitogen-activated protein kinase (MAPK) pathway through extracellular
  regulated protein kinases (ERK), p38 or c-Jun N-terminal kinase (JNK), which stimulate
  the activator protein-1 (AP-1). NF-κB and AP-1, then bind DNA and stimulate the
  production of pro-inflammatory cytokines and chemokines. In contrast, IL-38 acts
  as an antagonist of IL-1R1 and IL-36R, restraining the recruitment of IL-1RAcP and
  the binding of agonists, similar to what occurs for IL-1Ra and IL-36Ra. IL-1Ra and
  IL-36Ra recruit the inhibitory receptor single immunoglobulin IL-1R-related molecule
  (SIGIRR), which interferes with the TIR domain to exert antagonist properties, it
  remains unknown whether IL-38 can recruit SIGIRR. In addition, truncated IL-38 antagonizes
  IL-RAPL1 by recruiting a not-yet-identified inhibitory coreceptor and suppressing
  the JNK/AP1 pathway, full-length IL-38 activates the pathway.
pmcid: PMC6723600
papertitle: 'IL-38: A New Player in Inflammatory Autoimmune Disorders.'
reftext: Lihui Xie, et al. Biomolecules. 2019 Aug;9(8):345.
pmc_ranked_result_index: '47273'
pathway_score: 0.8739814
filename: biomolecules-09-00345-g001.jpg
figtitle: IL-38 signaling pathways
year: '2019'
organisms:
- Cricetulus griseus
- Mus musculus
- Rattus norvegicus
- Candida albicans 11C
- Adeno-associated virus
- Candida albicans
- Homo sapiens
ndex: 938f14df-df1b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6723600__biomolecules-09-00345-g001.html
  '@type': Dataset
  description: IL-38 signaling pathways. The N-terminus of IL-38 requires cleavage,
    but which protease(s) is responsible remains unknown. The process may involve
    an intra- or extracellular protease(s). IL-38 is mainly reported to exist in two
    forms—a truncated form and a full-length form. However, which form(s) of IL-38
    is naturally present in the human body remains unknown. Interleukin-1 receptor
    1 (IL-1R1) and IL-36R are activated by the agonists IL-1 and IL-36, respectively.
    The heterodimeric receptor complex consisting of IL-1R1 or IL-36R and interleukin-1
    receptor accessory protein (IL-1RAcP) results in myeloid differentiation primary
    response 88 (MyD88) recruitment through the intracellular toll-interleukin 1 receptor
    (TIR) domain, and the downstream signaling pathways that are activated include
    (A) the nuclear factor kappa B (NF-κB) pathway and (B) the mitogen-activated protein
    kinase (MAPK) pathway through extracellular regulated protein kinases (ERK), p38
    or c-Jun N-terminal kinase (JNK), which stimulate the activator protein-1 (AP-1).
    NF-κB and AP-1, then bind DNA and stimulate the production of pro-inflammatory
    cytokines and chemokines. In contrast, IL-38 acts as an antagonist of IL-1R1 and
    IL-36R, restraining the recruitment of IL-1RAcP and the binding of agonists, similar
    to what occurs for IL-1Ra and IL-36Ra. IL-1Ra and IL-36Ra recruit the inhibitory
    receptor single immunoglobulin IL-1R-related molecule (SIGIRR), which interferes
    with the TIR domain to exert antagonist properties, it remains unknown whether
    IL-38 can recruit SIGIRR. In addition, truncated IL-38 antagonizes IL-RAPL1 by
    recruiting a not-yet-identified inhibitory coreceptor and suppressing the JNK/AP1
    pathway, full-length IL-38 activates the pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - REL
  - MAPK10
  - NFKB1
  - NFKB2
  - FOSL1
  - CXCL13
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL8
  - CXCL10
  - FOS
  - MAPK8
  - MAPK9
  - JUN
  - JUNB
  - JUND
  - CXCL12
  - CXCL14
  - MAPK3
  - MAPK1
  - IL1A
  - IL1B
  - IL1R1
  - IL1RN
  - IL36RN
  - FOSB
  - FOSL2
  - CXCL6
  - CXCL11
  - CXCL5
  - MAPK14
  - MAPK11
  - RELA
  - RELB
  - PF4
  - PPBP
  - MAPK13
  - MAPK12
  - CXCL9
  - SIGIRR
genes:
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1R1
  symbol: IL1R1
  source: hgnc_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: IL-1Ra
  symbol: IL1RA
  source: hgnc_alias_symbol
  hgnc_symbol: IL1RN
  entrez: '3557'
- word: IL-36RA
  symbol: IL36RA
  source: hgnc_alias_symbol
  hgnc_symbol: IL36RN
  entrez: '26525'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Cytokines,chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: SIGIRR
  symbol: SIGIRR
  source: hgnc_symbol
  hgnc_symbol: SIGIRR
  entrez: '59307'
chemicals: []
diseases: []
figid_alias: PMC6723600__F1
redirect_from: /figures/PMC6723600__F1
figtype: Figure
---
